Genome sequence comparisons of serial multidrug-resistant Mycobacterium tuberculosis isolates over 21 years of infection in a single patient

Microbial Genomics

Volumn 1, Issue 5, 2015, Pages

  Meumann, Ella M ^a,b   Globan, Maria ^a,b   Fyfe, Janet A M ^a,b   Leslie, David ^a,b   Porter, Jessica L ^b,c   Seemann, Torsten ^b,c   Denholm, Justin ^a,b,c,d   Stinear, Timothy P ^b,c  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Doherty Institute for Infection and Immunity ^*  (Australia)

Author keywords

Antibiotic resistance; Clinical persistence; Evolution; Mycobacterium tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; QUINOLONE; RIFAMPICIN; STREPTOMYCIN;

AHPC GENE; ALLELE; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACA GENE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATE; CASE REPORT; CLINICAL ARTICLE; DISEASE COURSE; DNA SEQUENCE; ETHA GENE; FRAMESHIFT MUTATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENOTYPE; GIDB GENE; HUMAN; METC GENE; MSHA GENE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNCA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM ANALYSIS; TUBERCULOSIS; WHOLE GENOME SEQUENCING;

EID: 85011029340     PISSN: None     EISSN: 20575858     Source Type: Journal    
DOI: 10.1099/mgen.0.000037     Document Type: Article

References (35)

1. Buchmeier, N. & Fahey, R. C. (2006). The mshA gene encoding the glycosyltransferase of mycothiol biosynthesis is essential in Mycobacterium tuberculosis Erdman. FEMS Microbiol Lett 264, 74-79.
2. Coscolla, M. & Gagneux, S. (2010). Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov Today Dis Mech 7, e43-e59.
3. Domenech, P., Kobayashi, H., Lier, K., Walker, G. C. & Barry, C. E. III (2009). BacA, an ABC transporter involved in maintenance of chronic murine infections with Mycobacterium tuberculosis. J Bacteriol 191, 477-485.
4. Eldholm, V., Norheim, G., von der Lippe, B., Kinander, W., Dahle, U. R., Caugant, D. A., Mannsåker, T., Mengshoel, A. T., Dyrhol-Riise, A. M. & Balloux, F. (2014). Evolution of extensively drugresistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient. Genome Biol 15, 490.
5. Ford, C. B., Lin, P. L., Chase, M. R., Shah, R. R., Iartchouk, O., Galagan, J., Mohaideen, N., Ioerger, T. R., Sacchettini, J. C. & other authors (2011). Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet 43, 482-486.
6. Ford, C. B., Shah, R. R., Maeda, M. K., Gagneux, S., Murray, M. B., Cohen, T., Johnston, J. C., Gardy, J., Lipsitch, M. & Fortune, S. M. (2013). Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet 45, 784-790.
7. Gagneux, S., Long, C. D., Small, P. M., Van, T., Schoolnik G. K. & Bohannan, B. J. (2006). The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944-1946.
8. Gao, W., Cameron, D. R., Davies, J. K., Kostoulias, X., Stepnell, J., Tuck, K. L., Yeaman, M. R., Peleg, A. Y., Stinear, T. P. & Howden, B. P. (2013). The RpoBH481Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus. J Infect Dis 207, 929-939.
9. Glazebrook, J., Ichige, A. & Walker, G. C. (1993). A Rhizobium meliloti homolog of the Escherichia coli peptide-antibiotic transport protein SbmA is essential for bacteroid development. Genes Dev 7, 1485-1497.
10. Hawkey, J., Hamidian, M., Wick, R. R., Edwards, D. J., Billman-Jacobe, H., Hall, R. M. & Holt, K. E. (2015). ISMapper: identifying transposase insertion sites in bacterial genomes from short read sequence data. BMC Genomics 16, 667.
11. Hillemann, D., Hoffner, S., Cirillo, D., Drobniewski, F., Richter, E., Rüsch-Gerdes, S. & Baltic-Nordic TB-Laboratory Network, TB PAN-NET & ECDC ERLN-TB Networks (2013). First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries. PL One 8, e76765.
12. Kapur, V., Li, L. L., Hamrick, M. R., Plikaytis, B. B., Shinnick, T. M., Telenti, A., Jacobs, W. R., Jr, Banerjee, A., Cole, S. & other authors (1995). Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med 119, 131-138.
13. Lier, K., Phillips, R. W., Grippe, V. K., Roop, R. M., II & Walker, G. C. (2000). Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival. Science 287, 2492-2493.
14. Li, G., Zhang, J., Guo, Q., Wei, J., Jiang, Y., Zhao, X., Zhao, L. L., Liu, Z., Lu, J. & Wan, K. (2015). Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates. J Antibiot (Tokyo) 68, 431-435.
15. Mariam, S. H., Werngren, J., Aronsson, J., Hoffner, S. & Andersson, D. I. (2011). Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-terminfection and antibiotic treatment. PLoS One 6, e21147.
16. Müller, B., Borrell, S., Rose, G. & Gagneux, S. (2013). The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet 29, 160-169.
17. Newton, G. L., Ta, P., Bzymek, K. P. & Fahey, R. C. (2006). Biochemistry of the initial steps of mycothiol biosynthesis. J Biol Chem 281, 33910-33920.
18. Newton, G. L., Buchmeier, N. & Fahey, R. C. (2008). Biosynthesis and functions of mycothiol, the unique protective thiol of Actinobacteria. Microbiol Mol Biol Rev 72, 471-494.
19. Okamoto, S., Tamaru, A., Nakajima, C., Nishimura, K., Tanaka, Y., Tokuyama, S., Suzuki, Y. & Ochi, K. (2007). Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol Microbiol 63, 1096-1106.
20. Rengarajan, J., Sassetti, C. M., Naroditskaya, V., Sloutsky, A., Bloom, B. R. & Rubin, E. J. (2004). The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol 53, 275-282.
21. Ross, B. C., Raios, K., Jackson, K., Sievers, A. & Dwyer, B. (1991). Differentiation of Mycobacterium tuberculosis strains by use of a nonradioactive Southern blot hybridization method. J Infect Dis 163, 904-907.
22. Sandgren, A., Strong, M., Muthukrishnan, P., Weiner, B. K., Church, G. M. & Murray, M. B. (2009). Tuberculosis Drug Resistance Mutation Database. PL Med 6, e1000002.
23. Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. & Musser, J. M. (1997a). Analysis of the oxyR-ahpC region in isoniazid-resistant and-susceptible Mycobacterium tuberculosis complex organisms reco-vered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother 41, 600-606.
24. Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R. Jr, Telenti, A. & Musser, J. M. (1997b). Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 41, 1677-1681.
25. Sun, G., Luo, T., Yang, C., Dong, X., Li, J., Zhu, Y., Zheng, H., Tian, W., Wang, S. & other authors (2012). Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J Infect Dis 206, 1724-1733.
26. Tiwari, B. M., Kannan, N., Vemu, L. & Raghunand, T. R. (2012). The Mycobacterium tuberculosis PE proteins Rv0285 and Rv1386 modulate innate immunity and mediate bacillary survival in macrophages. PL One 7, e51686.
27. Turcios, L., Casart, Y., Florez, I., de Waard, J. & Salazar, L. (2009). Characterization of IS6110 insertions in the dnaA-dnaN intergenic region of Mycobacterium tuberculosis clinical isolates. Clin Microbiol Infect 15, 200-203.
28. Vilchèze, C., Av-Gay, Y., Attarian, R., Liu, Z., Hazbón, M. H., Colangeli, R., Chen, B., Liu, W., Alland, D. & other authors (2008). Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol Microbiol 69, 1316-1329.
29. Walker, T. M., Kohl, T. A., Omar, S. V., Hedge, J., Del Ojo Elias, C., Bradley, P., Iqbal, Z., Feuerriegel, S., Niehaus, K. E. & other authors (2015). Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15, 1193-1202.
30. Witney, A. A., Gould, K. A., Arnold, A., Coleman, D., Delgado, R., Dhillon, J., Pond, M. J., Pope, C. F., Planche, T. D. & other authors (2015). Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases. J Clin Microbiol 53, 1473-1483.
31. Yousuf, S., Angara, R., Vindal, V. & Ranjan, A. (2015). Rv0494 is a starvation-inducible, auto-regulatory Fa-like regulator from Mycobacterium tuberculosis. Microbiology 161, 463-476.
32. Zaunbrecher, M. A., Sikes, R. D. Jr, Metchock, B., Shinnick, T. M. & Posey, J. E. (2009). Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 106, 20004-20009.
33. Zetola, N. M., Modongo, C., Moonan, P. K., Ncube, R., Matlhagela, K., Sepako, E., Collman, R. G. & Bisson, G. P. (2014). Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests. J Infect Dis 209, 1754-1763.
34. Stinear, T. Fihare http://dx.doi.org/10.6084/m9.figshare.1561411 (2015).
35. Stinear, T. European Nucleotide Archive (ENA) http://www.ebi.ac.uk/ena/data/view/ERP011175 (2015).